Biomea Fusion, Inc. (BMEA) Discusses Top Line Results From COVALENT-112 Trial of Icovamenib in Type 1 Diabetes Transcript
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Hitchcock - Interim CEO & DirectorJuan Pablo FriasStephan Morris - Chief Development Officer Conference Call Participants Edward Tenthoff - Piper Sandler & Co., Research DivisionCha Cha Yang - Jefferies LLC, Research DivisionMichael King - Rodman & Renshaw ResearchJoseph Pantginis - H.C. Wainwright & Co, LLC, Research DivisionYigal Nochomovitz - Citigroup Inc., Research DivisionJoyce Zhou - JPMorgan Chase & Co, Research Division Presentation Operator Good day, and thank you for standing by.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Hitchcock - Interim CEO & DirectorJuan Pablo FriasStephan Morris - Chief Development Officer Conference Call Participants Edward Tenthoff - Piper Sandler & Co., Research DivisionCha Cha Yang - Jefferies LLC, Research DivisionMichael King -
- ▪Wainwright & Co, LLC, Research DivisionYigal Nochomovitz - Citigroup Inc., Research DivisionJoyce Zhou - JPMorgan Chase & Co, Research Division Presentation Operator Good day, and thank you for standing by.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895293-biomea-fusion-inc-bmea-discusses-top-line-results-from-covalentminus-112-trial-of-icovamenib"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"https://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
